Brief: Erytech Announces That The Commercial Court Has Rejected Akkadian's Request To Postpone The Vote On The Merger With Pherecydes Pharma
14/06/2023 19:03
June 14 (Reuters) - Pherecydes Pharma SA ALPHE.PA :
* REG-ERYTECH ANNOUNCES THAT THE COMMERCIAL COURT HAS
REJECTED
AKKADIAN'S REQUEST TO POSTPONE THE VOTE ON THE MERGER WITH
PHERECYDES PHARMA
* ERYTECH PHARMA SA - ERYTECH SHAREHOLDERS WILL BE ABLE TO
LEGITIMATELY VOTE ON MERGER ON JUNE 23, 2023
* ERYTECH PHARMA SA - EXPERT HAS BEEN APPOINTED TO EXAMINE
MERGER
PARITY AND MUST SUBMIT HIS REPORT TO PARTIES WITHIN 4 MONTHS
* ERYTECH PHARMA SA - AKKADIAN PARTNERS HAS TO COVER COSTS
OF THIS
EXPERT APPRAISAL
* ERYTECH PHARMA SA - AKKADIAN PARTNERS HAS ALSO BEEN
ORDERED TO
INDEMNIFY ERYTECH FOR COSTS INCURRED BY COMPANY IN THIS
PROCEDURE
Source text for Eikon: ID:nGNE898XKt
Further company coverage: ALPHE.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pherecydes Pharma SA
See all newsBrief: Erytech And Pherecydes Announce Merger And Name Change To Phaxiam Therapeutics
Brief: Pherecydes Pharma SA - Pherecydes Pharma And Erytech Pharma Shareholders Approve Merger Between Two Companies To Create Phaxiam Therapeutics
Brief: Erytech Announces That The Commercial Court Has Rejected Akkadian's Request To Postpone The Vote On The Merger With Pherecydes Pharma
Brief: Erytech: urges shareholders to vote for merger with Pherecydes and dismisses Akkadian's moves
Brief: Erytech Pharma Says Akkadian Has Initiated Proceedings To Postpone Vote On Merger With Pherecydes